Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - leflunomide 100mg - film coated tablet - 100 mg - active: leflunomide 100mg excipient: colloidal silicon dioxide crospovidone hypromellose lactose monohydrate macrogol 8000 magnesium stearate maize starch povidone purified talc titanium dioxide - arava is indicated for the treatment of: · rheumatoid arthritis, to improve signs and symptoms to retard joint destruction and to improve functional ability and quality of life. leflunomide may be used in patients who have failed to respond to other treatments or as a first line of treatment in patients who have a contraindication to other treatments. · active psoriatic arthritis. arava is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease

Egyptaland - enska - EDA (Egyptian Drug Authority)

sanofi- aventis egypt -

Singapúr - enska - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - alirocumab - injection, solution - alirocumab 150mg

Singapúr - enska - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - alirocumab - injection, solution - alirocumab 75mg

Armenía - enska - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sanofi-aventis deutschland gmbh - insulin glargine - solution for injection - 300iu/ml

Evrópusambandið - enska - EMA (European Medicines Agency)

sanofi-aventis deutschland gmbh - insulin glulisine - diabetes mellitus - drugs used in diabetes - treatment of adults, adolescents and children, six years or older with diabetes mellitus, where treatment with insulin is required.

Evrópusambandið - enska - EMA (European Medicines Agency)

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insuman rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.

Evrópusambandið - enska - EMA (European Medicines Agency)

sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antithrombotic agents - acute coronary syndromemyocardial infarction

Ísrael - enska - Ministry of Health

sanofi - aventis israel ltd - aluminium hydroxide; magnesium hydroxide - suspension - aluminium hydroxide 175 mg / 5 ml; magnesium hydroxide 200 mg / 5 ml - ordinary salt combinations - ordinary salt combinations - antacid.

Írland - enska - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 150 milligram(s)/millilitre - heparin group; enoxaparin